Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
2016 · New England Journal of Medicine · 6,187 citations
https://doi.org/10.1056/nejmoa1607141
T
Tina Vilsbøll
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
724
Papers
35.2K
Citations
87
h-index
341
i10-index
Tina Vilsbøll is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Diabetes Treatment and Management & Diabetes Management and Research & Pancreatic function and diabetes. The author has an h-index of 87, co-authored 616 publications.
ORCID: 0000-0002-0456-6787Papers by this author
worksOral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
2019 · New England Journal of Medicine · 1,826 citations
https://doi.org/10.1056/nejmoa1901118
Recovery of gut microbiota of healthy adults following antibiotic exposure
2018 · Nature Microbiology · 839 citations
https://doi.org/10.1038/s41564-018-0257-9
Role of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption
2003 · Journal of Bone and Mineral Research · 327 citations
https://doi.org/10.1359/jbmr.2003.18.12.2180
Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial
2022 · JCI Insight · 194 citations
https://doi.org/10.1172/jci.insight.159863
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine
2023 · Nature Medicine · 187 citations
https://doi.org/10.1038/s41591-023-02502-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat